Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice

By sjmartinez • September 27, 2023

Teper Y, Ye L, Waldron RT, Lugea A, Sun X, Sinnett-Smith J, Hines OJ, Pandol SJ, Rozengurt E, Eibl G. Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice. Sci Rep. 2023 Sep 26;13(1):16144. doi: 10.1038/s41598-023-43498-9. PMID: 37752238.

Tags: Cedars Sinai DoM, Digestive Diseases, Publications

PRIME 2.0: An Update to The Proposed Requirements for Cardiovascular Imaging-Related Machine Learning Evaluation Checklist

Kagiyama N, Tokodi M, Hathaway QA, Arnaout R, Davies R, Dey D, Duchateau N, Fraser AG, Goto S, Jamthikar AD, Lam CSP, Oikonomou EK, Ouyang[...]

Patient and Caregiver Outcomes of Health System, Community-Based, and Usual Dementia Care: A Prespecified Analysis of the Dementia Care Study (D-CARE) Randomized Clinical Trial

Reuben DB, Stevens AB, Gill TM, Williamson J, Volpi E, Lichtenstein ML, Jennings LA, Galloway R, Summapund J, Araujo K, Bass D, Weitzman L, Tan[...]

Reply to Letter on “Sex-Specific Trends and Demographic vs Epidemiologic Drivers of Alcohol-Related Cirrhosis in the U.S., 2021-2040”

Danpanichkul P, Diaz LA, Arab JP, Singal AG, Yang JD. Reply to Letter on "Sex-Specific Trends and Demographic vs Epidemiologic Drivers of Alcohol-Related Cirrhosis in[...]